These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11441324)

  • 41. Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial.
    Ranasinghe P; Wathurapatha WS; Galappatthy P; Katulanda P; Jayawardena R; Constantine GR
    J Diabetes; 2018 May; 10(5):386-397. PubMed ID: 29072815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zinc Supplementation Does Not Affect Glucagon Response to Intravenous Glucose and Insulin Infusion in Patients with Well-Controlled Type 2 Diabetes.
    Pérez A; Rojas P; Carrasco F; Basfi-Fer K; Pérez-Bravo F; Codoceo J; Inostroza J; Ruz M
    Biol Trace Elem Res; 2018 Oct; 185(2):255-261. PubMed ID: 29374382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis.
    Hemilä H; Petrus EJ; Fitzgerald JT; Prasad A
    Br J Clin Pharmacol; 2016 Nov; 82(5):1393-1398. PubMed ID: 27378206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zinc for the common cold.
    Marshall I
    Cochrane Database Syst Rev; 2000; (2):CD001364. PubMed ID: 10796643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of zinc against common cold viruses: an overview.
    Hulisz D
    J Am Pharm Assoc (2003); 2004; 44(5):594-603. PubMed ID: 15496046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
    Edelman SV; Callahan P; Deeb LC
    Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
    Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
    Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials.
    Hemilä H
    BMC Med Res Methodol; 2017 May; 17(1):82. PubMed ID: 28494765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis.
    Lindsey CC; Carter AW; Mangum S; Greene D; Richardson A; Brown S; McCandless B
    Diabetes Technol Ther; 2002; 4(5):637-42. PubMed ID: 12450445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. WITHDRAWN: Zinc for the common cold.
    Marshall I
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001364. PubMed ID: 17636670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zinc lozenges: cold cure or candy? Solution chemistry determinations.
    Eby GA
    Biosci Rep; 2004 Feb; 24(1):23-39. PubMed ID: 15499830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage.
    Hemilä H
    JRSM Open; 2017 May; 8(5):2054270417694291. PubMed ID: 28515951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of bexagliflozin in cats with poorly regulated diabetes mellitus.
    Benedict SL; Mahony OM; McKee TS; Bergman PJ
    Can J Vet Res; 2022 Jan; 86(1):52-58. PubMed ID: 34975223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis.
    Hemilä H; Chalker E
    BMC Fam Pract; 2015 Feb; 16():24. PubMed ID: 25888289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of zinc on the olfactory neuroepithelium and olfactory bulbs of the Sprague-Dawley rat after oral administration of zinc-gluconate trihydrate.
    Carboni AA; Cullen KJ; Lavelle WG
    Am J Rhinol; 2006; 20(3):262-8. PubMed ID: 16871926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.